Skip to main content
. 2013 Mar 22;142(1):200–207. doi: 10.1017/S0950268813000617

Table 1.

Study population (first column; n = 25 521) and distribution of injecting drug users (IDUs) identified via record-linkage in each of the four data sources according to sex, birth cohort, health board of residence and calendar year period of HCV diagnosis. The sensitivity of IDU status on the HCV Diagnosis database is computed by considering the IDUs identified by aggregating all four data sources as the ‘gold standard’

Covariate All HCV diagnosed HCV-diagnosed cases with IDU risk in the following data sources Sensitivity
(a) HCV Diag (b) HIV Test (c) SDMD (d) SMR01/Deaths
n % n % n % n % n % %
All 25 521 14 836 9761 12 410 7625 79·0
Sex
 Female 8177 32·0 4415 29·8 2524 25·9 3806 30·7 2361 31·0 77·5
 Male 17 344 68·0 10 421 70·2 7237 74·1 8604 69·3 5264 69·0 79·6
Birth cohort
 <1960 5168 20·2 1530 10·3 889 9·1 790 6·4 771 10·1 78·1
 1960–69 8894 34·8 5557 37·5 3637 37·3 4260 34·3 2843 37·3 81·2
 1970–79 8812 34·5 6119 41·2 4148 42·5 5706 46·0 3170 41·6 78·6
 1980+ 2647 10·4 1630 11·0 1087 11·1 1654 13·3 841 11·0 74·0
Health board
 GGC 10 679 41·8 6743 45·5 4090 41·9 5537 44·6 3045 39·9 82·5
 Other 14 842 58·2 8093 54·5 5671 58·1 6873 55·4 4580 60·1 76·3
Period of HCV diagnosis
 <1995 2290 9·0 1014 6·8 686 7·0 585 4·7 584 7·7 83·7
 1995–99 7163 28·1 4597 31·0 2993 30·7 3388 27·3 2329 30·5 84·3
 2000–04 8168 32·0 5341 36·0 3518 36·0 4436 35·7 2642 34·6 82·4
 2005–09 7900 31·0 3884 26·2 2564 26·3 4001 32·2 2070 27·1 68·9

HCV Diag, HCV Diagnosis database; SDMD, Scottish drug misuse database; SMR01/Deaths, Scottish Morbidity Records hospital discharge/deaths data; GGC, Greater Glasgow & Clyde Health Board.